Dataset
Download summary statistics | README
Publications
Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control.
Pollack S, et al.
Diabetes. 2019 Feb; 68(2): 441–456. doi: 10.2337/db18-0567
PMID:30487263
Dataset phenotypes
- Diabetic retinopathy (DR) vs no DR
- Diabetic retinopathy (DR) vs no DR acct DoD-GC (accounting for duration of diabetes and glycemic control)
- Proliferative diabetic retinopathy (PDR) vs no PDR
- Proliferative diabetic retinopathy (PDR) vs no PDR acct DoD-GC (accounting for duration of diabetes and glycemic control)
- Non-proliferative diabetic retinopathy vs no DR
- Non-proliferative diabetic retinopathy vs no DR acct DoD-GC (accounting for duration of diabetes and glycemic control)
- Proliferative diabetic retinopathy vs no DR
- Proliferative diabetic retinopathy vs no DR acct DoD-GC (accounting for duration of diabetes and glycemic control)
Dataset subjects (primary "any DR" analysis)
Cases | Controls | Cohort(Click to view selection criteria for cases and controls) | Ancestry |
---|---|---|---|
274 | 56 | African American Proliferative Diabetic Retinopathy Study (AAPDR) | African American |
96 | 265 | Atherosclerosis Risk in Communities Study (ARIC) | African American |
19 | 35 | Cardiovascular Health Study (CHS) | African American |
330 | 167 | Family Study of Nephropathy and Diabetes-Eye (FIND-Eye) | African American |
91 | 160 | Jackson Heart Study (JHS) | African American |
101 | 258 | Multiethnic Study of Atherosclerosis (MESA) | African American |
Experiment summary
This study analyzed genetic associations in type 2 diabetics for four diabetic retinopathy (DR) case-control definitions. Two datasets are incorporated into the Knowledge Portal: one for subjects of African American ancestry and one for subjects of European ancestry. The primary case-control definition compared any DR to no DR using the Early Treatment Diabetic Retinopathy Study (ETDRS) score thresholds ETDRS ≥ 14 for cases and ETDRS < 14 for controls. Secondary analyses compared:
- patients with proliferative diabetic retinopathy (PDR) to those without PDR (ETDRS ≥ 60 vs. ETDRS < 60)
- patients with nonproliferative DR (NPDR) or worse to those without DR (ETDRS ≥ 30 vs. ETDRS < 14)
- patients with PDR to those without DR (ETDRS ≥ 60 vs. ETDRS < 14)
Analyses were performed with or without liability threshold modeling to account for the strongest two covariates, duration of diabetes and glycemic control.